Pharmacology & ToxicologybioRxiv
GLP-1 Receptor Agonist Improves Metabolic Disease in a Pre-clinical Model of Lipodystrophy
A. Roumane, G. D. Mcilroy, N. Sommer…·J. J. Rochford
This study shows that liraglutide, a GLP-1R agonist, improves metabolic disease in seipin knockout mice, a model of lipodystrophy, by enhancing insulin secretion and reducing liver fibrosis.
DOI 10.3389/fendo.2024.1379228